1. Home
  2. PMCB vs QCLS Comparison

PMCB vs QCLS Comparison

Compare PMCB & QCLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.44

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Q/C Technologies Inc.

QCLS

Q/C Technologies Inc.

HOLD

Current Price

$0.87

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
QCLS
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.2M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
PMCB
QCLS
Price
$0.44
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
302.6K
★ 6.0M
Earning Date
03-17-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 22.33
EPS
★ N/A
N/A
Revenue
N/A
★ $3,929,527.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.71
52 Week Low
$0.33
$0.42
52 Week High
$1.51
$8.17

Technical Indicators

Market Signals
Indicator
PMCB
QCLS
Relative Strength Index (RSI) 44.03 31.72
Support Level $0.33 $0.42
Resistance Level $0.77 $4.09
Average True Range (ATR) 0.05 0.26
MACD 0.01 0.02
Stochastic Oscillator 63.10 28.63

Price Performance

Historical Comparison
PMCB
QCLS

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

Share on Social Networks: